- $354.93m
- $344.82m
- $13.55m
Annual income statement for CapsoVision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 9.75 | 11.8 | 13.6 |
| Cost of Revenue | |||
| Gross Profit | 5.49 | 6.38 | 7.17 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Total Operating Expenses | 21.1 | 31.7 | 39.1 |
| Operating Profit | -11.3 | -19.9 | -25.5 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -11.3 | -19.9 | -25.3 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -11.3 | -19.9 | -25.3 |
| Net Income Before Extraordinary Items | |||
| Net Income | -11.3 | -19.9 | -25.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -11.3 | -19.9 | -25.3 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.244 | -0.429 | -1.03 |
| Dividends per Share |